Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
NCT00272662
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Chemotherapy Induced Anemia
Cancer
Interventions
DRUG:
peginesatide
Sponsor
Affymax